Strong growth across all key metrics

Highlights

•  Monthly Recurring Revenue (MRR)1 of $4.6m @ December 2020 up 31%
•  Statutory Recurring revenue2 of $25.3m, up 26% on a pro forma basis
•  94% of total revenue is recurring revenue
•  Statutory Total revenue2 of $26.9m, up 18% on a pro forma basis
•  Gross Profit Margin3 of 87%
•  Pro Forma EBITDA4 of $6.9m, up from ($0.1m)
•  Statutory EBITDA5 of $1.4m including non-recurring IPO related costs
•  Pro Forma Net Profit after Tax (NPAT) of $1.5m, up from ($5.3m)
•  Statutory NPAT5 of ($5.9m) includes non-recurring finance and IPO related costs
•  Pro Forma Operating Cashflow (OCF) of $6.7m, 98% EBITDA4 to OCF conversion
•  Closing cash and funds on deposit of $31.5m, no debt
•  COVID-19 Update: No adverse impact from recent outbreaks
•  On track to meet FY21 Prospectus forecasts for key financial and operating metrics